+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel



Investigation of product quality between extemporaneously compounded progesterone vaginal suppositories and an approved progesterone vaginal gel



Drug Development and Industrial Pharmacy 30(10): 1069-1078



The purpose of this investigation was to compare quality parameters, including product appearance, content uniformity, pH, weight uniformity, microbial limit testing and preservative effectiveness testing on extemporaneously compounded progesterone vaginal suppositories obtained from 10 randomly chosen compounding pharmacies (90 suppositories each) across the United States, to the Food and Drug Administration (FDA) approved prescription progesterone gel product (Prochieve/Crinone) which is manufactured in a cGMP regulated facility. The content uniformity and pH were determined using qualified methods. The microbial limits testing and preservative effectiveness testing were conducted according to compendial methods. Only one pharmacy provided suppositories that were all within the potency limits required for the prescription progesterone gel product. The other pharmacies provided at least some suppositories where progesterone content was either subpotent or superpotent for progesterone. The pH of most of the compounded suppository products was in the range of 4.22 to 7.68 with a median of 6.30 (normal vaginal pH is <5), whereas the gel product was 2.80. For compounded product from one of the pharmacies, microbial limits testing indicated CDC group IVC-2 and Comamonas acidovorans were detected. This data indicates that pharmacy compounded delivery systems for progesterone should be used with caution.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 049403533

Download citation: RISBibTeXText

PMID: 15595573

DOI: 10.1081/ddc-200040251


Related references

Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories. American Journal of Obstetrics & Gynecology 156(1): 253-256, 1987

Quality of Progesterone Suppositories Prepared by FIRST-Progesterone Vaginal Suppository 50 Kit or Traditional Compounding Method: In Vitro Comparison. International Journal of Pharmaceutical Compounding 13(4): 342-344, 2009

A comparison of luteal phase support in graduated estradiol/progesterone replacement cycles using intramuscular progesterone alone vs combination with vaginal suppositories on outcome following frozen embryo transfer. Fertility & Sterility 81(Suppl 3): S30, 2004

A comparison of luteal phase support in graduated estradiol/progesterone replacement cycles using intramuscular progesterone alone versus combination with vaginal suppositories on outcome following frozen embryo transfer. Clinical and Experimental Obstetrics and Gynecology 32(2): 93-94, 2005

Pregnancy Outcomes for Women with Endometriosis Undergoing IVF with Luteal Phase Support via a Progesterone Vaginal Insert or Progesterone Vaginal Gel. Fertility and Sterility 99(3): S15-S16, 2013

Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo. Human Reproduction 33(11): 2131-2140, 2018

Vaginal micronized progesterone capsule versus vaginal progesterone gel for lutheal support in normoresponder IVF/ICSI-ET cycles. Pakistan Journal of Medical Sciences 31(2): 314-319, 2015

Arabin cervical pessary with vaginal progesterone versus vaginal progesterone for preventing preterm delivery. Journal of Maternal-Fetal & Neonatal Medicine 2019: 1-131, 2019

A prospective randomized multicentre study comparing vaginal progesterone gel and vaginal micronized progesterone tablets for luteal support after in vitro fertilization/intracytoplasmic sperm injection. Human Reproduction 27(12): 3467-3473, 2013

The physiologic effectiveness of progesterone vaginal suppositories. Journal of Clinical Endocrinology and Metabolism 14(12): 1564-1567, 1954

Trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. American Journal of Obstetrics and Gynecology 156(6): 1555-1556, 1987

Control of estrus and progesterone levels in heifers given intra vaginal progesterone coils and injections of progesterone and estrogen. Journal of Animal Science 44(6): 1026-1029, 1977

Preliminary report on the use of progesterone vaginal suppositories in the hormonal replacement therapy in postmenopause. Journal of Steroid Biochemistry 25(SUPPL): 23S, 1986

Sustained-release progesterone vaginal suppositories 3-development and clinical feasibility testing. Yakugaku Zasshi 133(6): 727-736, 2014

Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. Journal Of Assisted Reproduction & Genetics. 12(3): 205-209, 1995